StudySearch

CANOE

The purpose of the study is to learn more about how early life factors affect the development of childhood asthma and allergies.

Ravulizumab for COVID-19

This study intends to evaluate the safety and efficacy of ravulizumab for the treatment of COVID-19 severe pneumonia, acute lung injury or acute respiratory distress syndrome (ARDS).

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP PHASE II STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF TWO DIFFERENT DOSE REGIMENS OF IFX-1 AS ADD-ON TO STANDARD OF CARE IN SUBJECTS WITH GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA)

This clinical research study will look at an investigational study drug called IFX-1. It is being investigated for the first time in people who have granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).